Injury and the infiltration of LDL particles into the arterial wall, is only part of the cardiovascular disease (CVD) story. The inflammatory response to injury is a primary contributor to residual risk for cardiovascular events. Measuring inflammatory biomarkers in patients being treated for elevated LDL-C levels may provide deeper insight to help reduce CVD risk.
Download our white paper to:
Inflammatory markers may help physicians make more informed decisions on the next steps to address both injury and inflammation. Find out how in “Inflammatory Markers in Cardiovascular Health: A Quick Overview.”
Complete the form and click submit.
*Indicates required fields